secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0001628280-23-017225
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Q1 capitated revenue up 11%; net loss improves 14%; medical margin surges 58%
--------------------------------------------------------------------------------

- Capitated revenue $298.7M (+11% YoY); net loss $52.4M, improved from $60.8M in Q1 2022.
- Medical margin $39.2M (13.1% of capitated revenue), up 58% YoY; network contribution $16.5M (+114%).
- Adjusted EBITDA loss $19.1M; full-year guidance raised to loss $35-55M from prior expectations.
- FY 2023 guidance: revenue $1.2-1.25B, medical margin $155-175M, members 115k-120k.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000162828023017225/0001628280-23-017225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000162828023017225/piii-20230510.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-017225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer